- Home
- NVCR vs CNNE Comparison
NVCR vs CNNE Comparison
Compare NVCR & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- CNNE
- Stock Information
- Founded
- NVCR 2000
- CNNE 2014
- Country
- NVCR Switzerland
- CNNE United States
- Employees
- NVCR N/A
- CNNE N/A
- Industry
- NVCR Medical/Dental Instruments
- CNNE Restaurants
- Sector
- NVCR Health Care
- CNNE Consumer Discretionary
- Exchange
- NVCR Nasdaq
- CNNE Nasdaq
- Market Cap
- NVCR 1.4B
- CNNE 1.2B
- IPO Year
- NVCR 2015
- CNNE N/A
- Fundamental
- Price
- NVCR $12.43
- CNNE $18.50
- Analyst Decision
- NVCR Buy
- CNNE Buy
- Analyst Count
- NVCR 7
- CNNE 3
- Target Price
- NVCR $28.79
- CNNE $23.33
- AVG Volume (30 Days)
- NVCR 1.9M
- CNNE 744.0K
- Earning Date
- NVCR 07-24-2025
- CNNE 08-11-2025
- Dividend Yield
- NVCR N/A
- CNNE 3.32%
- EPS Growth
- NVCR N/A
- CNNE N/A
- EPS
- NVCR N/A
- CNNE N/A
- Revenue
- NVCR $630,160,000.00
- CNNE $437,200,000.00
- Revenue This Year
- NVCR $6.68
- CNNE N/A
- Revenue Next Year
- NVCR $7.01
- CNNE $2.03
- P/E Ratio
- NVCR N/A
- CNNE N/A
- Revenue Growth
- NVCR 14.58
- CNNE N/A
- 52 Week Low
- NVCR $10.87
- CNNE $15.92
- 52 Week High
- NVCR $34.13
- CNNE $22.36
- Technical
- Relative Strength Index (RSI)
- NVCR 46.30
- CNNE 38.42
- Support Level
- NVCR $11.55
- CNNE $17.69
- Resistance Level
- NVCR $12.26
- CNNE $18.25
- Average True Range (ATR)
- NVCR 0.46
- CNNE 0.60
- MACD
- NVCR 0.30
- CNNE -0.12
- Stochastic Oscillator
- NVCR 97.50
- CNNE 28.97
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.